Next Article in Journal
In Vitro Study on Antihypertensive and Antihypercholesterolemic Effects of a Curcumin Nanoemulsion
Previous Article in Journal
Detection of HER2 Gene Polymorphism in Breast Cancer: PCR Optimization Study
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Sci. Pharm.
Volume 84
Issue 1
10.3797/scipharm.ISP.2015.04
scipharm-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2016). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Removing a Cystein Group On Interferon Alpha 2b at Position 2 and 99 does Not Diminish Antitumor Activity of the Protein, Even Better

by
Heni RACHMAWATI
1,*,
Adhitya JESSICA
1,
Yeyet Cahyati SUMIRTAPUTRA
1,
Debbie Sofie RETNONINGRUM
1,
Amirah ADLIA
2 and
Ratih Asmana NINGRUM
3
1
School of Pharmacy, Bandung Institute of Technology, Ganesha 10, 40132, Bandung, Indonesia.
2
Department of Pharmacokinetics and Drug Delivery, University of Groningen, Antonius Deusinglaan I, Groningen, Netherlands.
3
Research Center for Biotechnology, Indonesian Institute of Sciences, Jalan Raya Bogor KM 46, 16911, Cibinong, Indonesia.
*
Author to whom correspondence should be addressed.
Sci. Pharm. 2016, 84(1), 113-130; https://doi.org/10.3797/scipharm.ISP.2015.04
Submission received: 5 September 2015 / Accepted: 15 December 2015 / Published: 14 February 2016
Versions Notes

Abstract

Interferon alpha 2b is the only standard therapeutic protein for hepatitis virus infections. Further study demonstrated that this protein also posseses antitumor activity in several cancerous organs. One main pathway of this antitumor activity is mediated through antiproliferation as well as proapoptotic effects. Previously, we have successfully developed recombinant human interferon alpha 2b (rhIFNα2b) by using a synthetic gene. In addition, two mutein forms of rhIFNα2b were generated to improve the characteristics of this protein. Two point mutations showed better pharmacokinetic profiles than one point mutation as well as the native form. In the present study, this mutein form was studied for ist antitumor effect in vitro using HepG2 cells. As a comparison, the native form as well as a commercial rIFNα2b were used. Several parameters were investigated including the MTT assay, cell viability test, cell cycle using flow cytometric analysis, and the genes and protein expressions involved in cell growth. The latest was observed to study the mechanism of rhIFNα2b. There was no significant difference in the MTT assay and cell viability after cells were treated with both forms of rhIFNα2b. However, the mutein rhIFNα2b tended to show better proapoptotic activity reflected by flow cytometric data, protein expression of pSTAT1, and DNA expression of caspase 3.
Keywords: Interferon alpha 2b; Antiproliferation; Apoptosis; p21k1; p27; Caspase 3; pSTAT1; Flow cytometri; Mutein Interferon alpha 2b; Antiproliferation; Apoptosis; p21k1; p27; Caspase 3; pSTAT1; Flow cytometri; Mutein

Share and Cite

MDPI and ACS Style

RACHMAWATI, H.; JESSICA, A.; SUMIRTAPUTRA, Y.C.; RETNONINGRUM, D.S.; ADLIA, A.; NINGRUM, R.A. Removing a Cystein Group On Interferon Alpha 2b at Position 2 and 99 does Not Diminish Antitumor Activity of the Protein, Even Better. Sci. Pharm. 2016, 84, 113-130. https://doi.org/10.3797/scipharm.ISP.2015.04

AMA Style

RACHMAWATI H, JESSICA A, SUMIRTAPUTRA YC, RETNONINGRUM DS, ADLIA A, NINGRUM RA. Removing a Cystein Group On Interferon Alpha 2b at Position 2 and 99 does Not Diminish Antitumor Activity of the Protein, Even Better. Scientia Pharmaceutica. 2016; 84(1):113-130. https://doi.org/10.3797/scipharm.ISP.2015.04

Chicago/Turabian Style

RACHMAWATI, Heni, Adhitya JESSICA, Yeyet Cahyati SUMIRTAPUTRA, Debbie Sofie RETNONINGRUM, Amirah ADLIA, and Ratih Asmana NINGRUM. 2016. "Removing a Cystein Group On Interferon Alpha 2b at Position 2 and 99 does Not Diminish Antitumor Activity of the Protein, Even Better" Scientia Pharmaceutica 84, no. 1: 113-130. https://doi.org/10.3797/scipharm.ISP.2015.04

APA Style

RACHMAWATI, H., JESSICA, A., SUMIRTAPUTRA, Y. C., RETNONINGRUM, D. S., ADLIA, A., & NINGRUM, R. A. (2016). Removing a Cystein Group On Interferon Alpha 2b at Position 2 and 99 does Not Diminish Antitumor Activity of the Protein, Even Better. Scientia Pharmaceutica, 84(1), 113-130. https://doi.org/10.3797/scipharm.ISP.2015.04

Article Metrics

Back to TopTop